Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
- PMID: 1695118
- DOI: 10.1002/1097-0142(19900715)66:2<321::aid-cncr2820660221>3.0.co;2-a
Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
Abstract
One hundred twenty-one cases of anaplastic carcinoma of the thyroid treated at M.D. Anderson Cancer Center, Houston, were reviewed. Anaplastic carcinoma is a rapidly growing neoplasm with a dismal prognosis. The mean survival of our patients was 7.2 +/- 10 months. A significant percentage of our patients (35%) had areas of well-differentiated thyroid carcinoma elsewhere, supporting the hypothesis that anaplastic thyroid carcinoma arises from preexisting well-differentiated thyroid carcinoma. Twenty-four of 30 tumors analyzed (84%) stained for keratin, 28 (93.3%) stained for vimentin, and ten (33%) stained for epithelial membrane antigen. Younger patients lived longer than older patients, and patients whose disease was earlier-stage at presentation responded better than patients with metastases at presentation. Radical surgery alone did not significantly increase survival duration over less radical surgery. The role of multimodality therapy needs further evaluation.
Similar articles
-
Immunohistology of anaplastic thyroid carcinoma. A study of 43 cases.Histopathology. 1987 Jun;11(6):567-80. doi: 10.1111/j.1365-2559.1987.tb02667.x. Histopathology. 1987. PMID: 2442086
-
Anaplastic thyroid tumors. Immunohistology.Am J Clin Pathol. 1987 Apr;87(4):434-42. doi: 10.1093/ajcp/87.4.434. Am J Clin Pathol. 1987. PMID: 2435145
-
Immunocytochemistry of anaplastic carcinoma of thyroid gland.Appl Pathol. 1989;7(2):122-33. Appl Pathol. 1989. PMID: 2471539
-
[Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].Rev Invest Clin. 1997 Mar-Apr;49(2):97-103. Rev Invest Clin. 1997. PMID: 9380971 Review. Spanish.
-
Anaplastic thyroid cancer: prevalence, diagnosis and treatment.Minerva Endocrinol. 2008 Dec;33(4):341-57. Minerva Endocrinol. 2008. PMID: 18923370 Review.
Cited by
-
Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.PLoS One. 2014 Dec 30;9(12):e116252. doi: 10.1371/journal.pone.0116252. eCollection 2014. PLoS One. 2014. PMID: 25548921 Free PMC article.
-
Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma.BMC Genomics. 2015 Mar 18;16(1):207. doi: 10.1186/s12864-015-1372-0. BMC Genomics. 2015. PMID: 25887408 Free PMC article.
-
Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.Surgery. 2010 Dec;148(6):1154-62; discussion 1162. doi: 10.1016/j.surg.2010.09.001. Surgery. 2010. PMID: 21134546 Free PMC article.
-
Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.Int J Clin Exp Pathol. 2010 Oct 1;3(8):755-62. Int J Clin Exp Pathol. 2010. PMID: 21151388 Free PMC article.
-
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.J Clin Invest. 1993 Apr;91(4):1753-60. doi: 10.1172/JCI116385. J Clin Invest. 1993. PMID: 8473515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical